These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study. Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802 [TBL] [Abstract][Full Text] [Related]
17. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Durandy Y Artif Organs; 2014 Jan; 38(1):11-8. PubMed ID: 24392866 [TBL] [Abstract][Full Text] [Related]
18. Currently available biomaterials for use in cardiopulmonary bypass. Belway D; Rubens FD Expert Rev Med Devices; 2006 May; 3(3):345-55. PubMed ID: 16681456 [TBL] [Abstract][Full Text] [Related]
19. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating. Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821 [TBL] [Abstract][Full Text] [Related]
20. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]